Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E29.75 EPS (ttm)1.25 Insider Own0.04% Shs Outstand5.58B Perf Week3.08%
Market Cap203.66B Forward P/E12.24 EPS next Y3.04 Insider Trans-7.80% Shs Float5.57B Perf Month6.35%
Income6.98B PEG2.96 EPS next Q0.79 Inst Own67.60% Short Float1.18% Perf Quarter-1.62%
Sales41.91B P/S4.86 EPS this Y-33.10% Inst Trans- Short Ratio2.07 Perf Half Y6.58%
Book/sh11.71 P/B3.17 EPS next Y-8.19% ROA5.70% Target Price40.54 Perf Year11.59%
Cash/sh2.23 P/C16.66 EPS next 5Y10.07% ROE14.90% 52W Range29.96 - 43.08 Perf YTD0.95%
Dividend1.56 P/FCF54.88 EPS past 5Y2.20% ROI7.60% 52W High-13.74% Beta0.71
Dividend %4.20% Quick Ratio1.00 Sales past 5Y-3.00% Gross Margin- 52W Low24.05% ATR0.59
Employees78500 Current Ratio1.40 Sales Q/Q11.80% Oper. Margin17.90% RSI (14)67.96 Volatility1.73% 1.59%
OptionableYes Debt/Eq0.63 EPS Q/Q125.10% Profit Margin22.90% Rel Volume1.07 Prev Close36.97
ShortableYes LT Debt/Eq0.59 EarningsMay 04 BMO Payout87.90% Avg Volume31.82M Price37.16
Recom2.60 SMA203.19% SMA505.77% SMA2004.23% Volume33,910,921 Change0.51%
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Apr-13-21 10:50PM  
09:26PM  
07:01PM  
06:20PM  
05:56PM  
05:54PM  
05:24PM  
05:05PM  
04:45PM  
03:11PM  
02:09PM  
01:25PM  
01:22PM  
12:56PM  
12:00PM  
11:39AM  
11:21AM  
10:51AM  
10:42AM  
10:28AM  
10:06AM  
10:04AM  
09:43AM  
09:28AM  
08:23AM  
08:02AM  
07:48AM  
07:15AM  
06:57AM  
06:03AM  
06:00AM  
05:51AM  
05:35AM  
05:12AM  
02:13AM  
Apr-12-21 10:35PM  
05:45PM  
03:28PM  
03:19PM  
02:43PM  
01:51PM  
11:53AM  
09:55AM  
09:33AM  
09:02AM  
08:50AM  
08:35AM  
07:25AM  
06:59AM  
06:58AM  
05:52AM  
02:52AM  
12:22AM  
Apr-11-21 12:13PM  
12:07PM  
06:01AM  
Apr-10-21 04:13PM  
04:01PM  
06:25AM  
06:00AM  
Apr-09-21 05:23PM  
04:58PM  
04:30PM  
04:20PM  
02:42PM  
02:13PM  
01:59PM  
01:39PM  
01:22PM  
11:46AM  
10:57AM  
10:56AM  
10:25AM  
09:55AM  
09:51AM  
09:25AM  
09:11AM  
09:06AM  
06:37AM  
06:00AM  
05:52AM  
04:33AM  
Apr-08-21 11:22PM  
06:21PM  
06:02PM  
05:00PM  
04:53PM  
03:23PM  
01:54PM  
01:23PM  
09:07AM  
07:15AM  
06:04AM  
04:50AM  
04:21AM  
02:44AM  
Apr-07-21 02:05PM  
02:03PM  
01:26PM  
12:28PM  
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM
BLAYLOCK RONALD EDirectorAug 06Buy38.5413,000501,08513,000Aug 10 08:07 AM
DAMICO JENNIFER B.SVP & ControllerJun 05Sale36.132,18178,8007,542Jun 08 04:29 PM
Dolsten MikaelPresident R&DMay 18Sale37.7895,3533,602,681174,918May 19 05:37 PM
DAMICO JENNIFER B.SVP & ControllerApr 29Sale38.352,18183,6419,647May 01 03:56 PM
JOHNSON RADY AExecutive Vice PresidentApr 29Sale38.3613,125503,47563,940May 01 03:56 PM
ROGERS DAWNExecutive Vice PresidentApr 29Sale38.1313,000495,6904,823May 01 03:56 PM
LANKLER DOUGLAS MExecutive Vice PresidentApr 29Sale37.8565,0002,460,37278,276May 01 03:56 PM